drugset / Trial / NCT03589495
Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries
RandomizedParallel-groupDouble-blindPrevention
Summary
The use of antioxidant agents in the prevention or decreasing the severity of postoperative systemic inflammatory response syndrome after colonic surgeries adopted nowadays. Therefore, it is of interest to investigate safety and efficacy of administrating short term intravenous (IV) N acetyl cysteine as add on to l alany l glutamine and total parenteral nutrition on the marker of oxidative stress malondialdehyde and anti- inflammatory marker tumor necrosis factor alpha in patients undergoing colonic surgeries through a prospective, randomized, double blinded, controlled clinical trial
Timeline
- Start
- 2015-07-30
- Primary completion
- 2016-10-15
- Completion
- 2016-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 50 mg/kg | Intravenous |
Indications
No indication recorded.